Works matching IS 08909091 AND DT 2019 AND VI 33 AND IP 1
Results: 12
Reducing Cancer Risk Through Diet.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 38
- By:
- Publication type:
- Article
Vitamin D and Omega-3 Supplements for Preventing Cancer and Other Chronic Diseases.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 36
- By:
- Publication type:
- Article
Pathologic Hip Fracture in a 49-Year-Old Man With Widespread Metastatic Sclerotic Bone Lesions.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 33
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 30
- By:
- Publication type:
- Article
The Emerging Profile of Immunotherapy Approaches in the Treatment of AML.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 28
- By:
- Publication type:
- Article
Management of Neutropenic Toxicity From CDK4/6 Inhibitors.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 26
- By:
- Publication type:
- Article
No "One Size Fits All" Approach Exists.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 21
- By:
- Publication type:
- Article
An Optimistic Time for Patients With Advanced Urothelial Carcinoma.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 12
- By:
- Publication type:
- Article
Current Strategies for the Management of Locoregional Breast Cancer Recurrence.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 19
- By:
- Publication type:
- Article
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 11
- By:
- Publication type:
- Article
Oncology Conference Highlights, Q4.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 8
- By:
- Publication type:
- Article
Key Advances in Oncology, 2018.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 1, p. 6
- By:
- Publication type:
- Article